USD 0.44
(-8.9%)
Breakdown | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Operating Cash Flow | -17.77 Million | 33.13 Million | 632.49 Thousand | 1.1 Million |
Net Income | -15.77 Million | 23.59 Million | 10.25 Million | -5.76 Million |
Depreciation & Amortization | 85.75 Thousand | 42.04 Thousand | 40.08 Thousand | 39.59 Thousand |
Deferred income taxes | -1076.00 | -341.00 | 208.00 | 789.00 |
Stock-based compensation | - | - | - | - |
Change in working capital | -2.08 Million | 9.49 Million | -9.66 Million | 6.82 Million |
Other non-cash items | - | 7.31 Million | -1305.00 | 4233.80 |
Investing Cash Flow | - | 7419.00 | 300 Thousand | -301.56 Thousand |
Investments in PPE | - | - | - | -1563.00 |
Acquisitions | - | 7419.00 | - | - |
Investment purchases | - | - | -58.07 Million | - |
Sales/Maturities of investments | - | - | - | - |
Other Investing Activities | - | - | 58.37 Million | -300 Thousand |
Financing Cash Flow | -1.57 Million | -21.91 Million | 1.3 Million | 4.88 Million |
Debt repayment | -12.54 Million | -1.02 Million | -165.44 Thousand | -4.43 Million |
Dividends payments | -902 Thousand | -16.95 Million | - | - |
Common Stock Repurchased | - | - | - | - |
Common Stock Issuance | - | - | 60.06 Million | - |
Other Financing Activities | -13.22 Million | -3.93 Million | -58.59 Million | 4.88 Million |
Accounts receivables | 2.97 Million | 3.87 Million | -5.4 Million | 425.86 Thousand |
Accounts payables | -489.32 Thousand | 262.02 Thousand | 183.36 Thousand | 283.79 Thousand |
Inventory | - | 1.47 Million | -4.83 Million | 1.97 Million |
Other working capital | -6.6 Million | 3.88 Million | 394.22 Thousand | 4.13 Million |
Cash at beginning of period | 19.99 Million | 10.35 Million | 8.11 Million | 2.42 Million |
Cash at end of period | 2.21 Million | 21.57 Million | 10.35 Million | 8.11 Million |
Capital Expenditure | - | - | - | -1563.00 |
Effect of forex changes on cash | - | -7419.00 | - | - |
Net cash flow / Change in cash | -17.77 Million | 11.21 Million | 2.23 Million | 5.69 Million |
Free Cash Flow | -17.77 Million | 33.13 Million | 632.49 Thousand | 1.1 Million |
Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -15.77 Million | - | - | 368.98 | 368.98 | 23.59 Million |
Depreciation & Amortization | 85.75 Thousand | - | - | - | - | 42.04 Thousand |
Deferred income taxes | -1076.00 | - | - | - | - | -341.00 |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -2.08 Million | - | - | - | - | 9.49 Million |
Other non-cash items | - | - | - | -368.98 | -368.98 | 7.31 Million |
Investing Cash Flow | - | - | - | - | - | 7419.00 |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | 7419.00 |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | -1.57 Million | - | - | - | - | -21.91 Million |
Debt repayment | -12.54 Million | - | - | - | - | -1.02 Million |
Dividends payments | -902 Thousand | - | - | - | - | -16.95 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -13.22 Million | - | - | - | - | -3.93 Million |
Accounts receivables | 2.97 Million | - | - | - | - | 3.87 Million |
Accounts payables | -489.32 Thousand | - | - | - | - | 262.02 Thousand |
Inventory | - | - | - | - | - | 1.47 Million |
Other working capital | -6.6 Million | - | - | - | - | 3.88 Million |
Cash at beginning of period | 19.99 Million | - | - | - | 11.89 Thousand | 10.35 Million |
Cash at end of period | 2.21 Million | - | - | - | 11.89 Thousand | 21.57 Million |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | -7419.00 |
Net cash flow / Change in cash | -17.77 Million | - | - | - | - | 11.21 Million |
Free Cash Flow | -17.77 Million | - | - | - | - | 33.13 Million |
016610
BIOCON
0JSP
601008
8273
PALI